TB Alliance ZeNix trial Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB
ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid India has the leading number of TB cases globally New Delhi/Berlin/Pretoria, July 16: The results of ZeNix, a Phase 3 clinical trial that took place in 11 sites across Georgia, Moldova, Russia, and […]
Read More